Serum Periostin as a Novel Biomarker for Predicting 30-Day Major Adverse Cardiac Events After Off-Pump Coronary Artery Bypass Grafting

Qian Su,* Zhipeng Deng,* Xiangqing Wei, Lu Li, Boxiang Du, Fei Guo, Yi Gu, Jie Song, Lei Yao Department of Anesthesiology, Affiliated Hospital 2 of Nantong University, Nantong, 226001, People’s Republic of China*These authors contributed equally to this workCorrespondence: Lei Yao; Jie S...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Su Q, Deng Z, Wei X, Li L, Du B, Guo F, Gu Y, Song J, Yao L
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2025-02-01
Colecção:	Therapeutics and Clinical Risk Management
Assuntos:	mace myocardial infarction opcab serum periostin ventricular remodeling
Acesso em linha:	https://www.dovepress.com/serum-periostin-as-a-novel-biomarker-for-predicting-30-day-major-adver-peer-reviewed-fulltext-article-TCRM
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!